Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights
Second quarter revenue of $12.4M, +53% year-over-year growth Second quarter pulse recurring revenue of $3.3M, +100% year-over-year growth First half revenue of $22.8M, +67% year-over-year growth, gross margin of 74.2%.
FDA clearance supported by a clinical study (n=67) and demonstrated treatment safety and efficacy utilizing SUPERB™, 97% of the treated participants in the trial showed improvement in the appearance of acne scars as assessed by masked evaluations
InMode Launches EvolveX Hands-free Platform for Non-Surgical Body Contouring with RF and EMS Technology
InMode Ltd. (Nasdaq: INMD) is proud to introduce Evolve, a non-invasive hands-free workstation designed to remodel skin, treat adipose tissue, and tone muscles. Total tissue targeting in one machine. The first of it’s kind.
As featured in the Aesthetics Journal: The new power duo guiding Sinclair through its next phase of growth Meet the New Team at Sinclair UKI
Global aesthetics specialist Sinclair is paving the way for a future of strategic innovation and expansion with two key executive appointments initiated to help spearhead Sinclair UKI’s ambition to be UK market leader.